Apollomics revenue was $0.00 for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, APLM annual revenue was $8.5M, with Infinity% growth year-over-year.
APLM past revenue growth
How has APLM's revenue growth performed historically?
On Jul 24, 2026, Apollomics (NASDAQ: APLM) reported Q2 2026 revenue of N/A up N/A year over year. In the same quarter last year, Apollomics's revenue was N/A.
What was Apollomics's revenue in 2025?
Apollomics's annual revenue for the twelve months ending Dec 31, 2025 was $8.50 million, a Infinity% increase year over year.
How much does Apollomics make in a day?
Based on Apollomics annual revenue for the past five years, APLM makes an average of $4,657.53 per day.
What was Apollomics's annual revenue growth in the past year?
As of Q4 2026, Apollomics's revenue has grown -100% year over year. This is 179.34 percentage points lower than the US Biotechnology industry revenue growth rate of 79.34%. Apollomics's revenue in the past year totaled $0.00.
How much does Apollomics make in a year?
Apollomics's revenue by year for the past five years is:
Apollomics's revenue for the twelve months ending Dec 31, 2025 was $8.50 million, a Infinity% increase year over year.
Apollomics's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
Apollomics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
Apollomics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Apollomics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.